Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome
Effectiveness of Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this Clinical Trial Study is to evaluate the clinical effectiveness of Radial Electrocorporeal Shockwave Therapy (rESWT) combined with exercise in individuals with iliotibial band syndrome (ITBS).The main question it aims to answer is : Does the addition of rESWT to standard ITBS exercise program reduce pain intensity and pain pressure threshold while improving lower extremity function and hip muscle strength in Individuals with Iliotibial Band syndrome (ITBS). Participants will be divided into two groups to be compared : The ShamTherapy Group (Control Group) that will receive the standard ITBS exercise program in addition to Sham rESWT, while the experimental group will receive the standard ITBS exercise program in addition to Radial Extracorporeal Shockwave Therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2026
CompletedFirst Submitted
Initial submission to the registry
June 19, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2026
June 25, 2026
June 1, 2026
2 months
June 19, 2026
June 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numerical Pain Rating Scale Score (NPRS)
To assess lateral knee pain intensity at rest and during activity Scores range from 0 (no pain) to 10 (worst pain)
baseline , immediately after the 4-week intervention period ( post intervention ) ,4 weeks after the intervention cessation as follow-up.
Secondary Outcomes (3)
Lower extremity Functional Scale (LEFS)
baseline , immediately after the 4-week intervention period ( post intervention ) ,4 weeks after the intervention cessation as follow-up.
Hip muscle strength dynamometer testing
baseline , immediately after the 4-week intervention period ( post intervention ) ,4 weeks after the intervention cessation as follow-up.
Pain Pressure Threshold algometry testing (PPT)
baseline , immediately after the 4-week intervention period ( post intervention ) ,4 weeks after the intervention cessation as follow-up.
Study Arms (2)
Sham rESWT and Standard ITBS Exercise Program
ACTIVE COMPARATORThis group will receive Sham rESWT and standard ITBS Exercise Program that will include ITB stretching and strengthening exercises mainly targeting hip abductors, hip external rotators and knee extensors.
rESWT combined with exercise program
EXPERIMENTALThe experimental group will receive the same standard exercise program in addition to rESWT on the distal portion of the ITB and the region of lateral femoral condyle.
Interventions
Standard ITBS Exercise Program : Flexibility and Strengthening Exercises will be delivered three times weekly over a 4-week period
Radial Extracorporeal Shockwave Therapy will be delivered once weekly for 4 weeks only.
Sham Extracorporal Shockwave therapy will be administered once a week for 4 weeks.
Eligibility Criteria
You may qualify if:
- Physically active individuals aged 18 and 45 years
- Have a clinical diagnosis of iliotibial band syndrome (ITBS) confirmed by physician within the previous four weeks.
- Report lateral knee pain during running or other functional activities
- No history of direct trauma
- Have a positive Noble compression or/and Ober test.
You may not qualify if:
- History of knee surgery,fracture , meniscal or ligamentous injury within the past year
- Any fracture involving the lower extremity within the previous six months
- Neurological disorders
- Lumbar radiculopathy
- Systemic inflammatory disease
- Any medical condition affecting gat or lower extremity function.
- Have received corticosteroid injection, shockwave therapy, or physical therapy treatment for ITBS within the previous six months
- Use of NDAID's or analgesics later than 2 weeks
- Individuals with contraindications to ESWT, including pregnancy, bleeding disorders, or use of anticoagulant medication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University Hospitals
Giza, Giza Governorate, 2356, Egypt
Related Publications (3)
Weckstrom K, Soderstrom J. Radial extracorporeal shockwave therapy compared with manual therapy in runners with iliotibial band syndrome. J Back Musculoskelet Rehabil. 2016;29(1):161-70. doi: 10.3233/BMR-150612.
PMID: 26406193BACKGROUNDMcKay J, Maffulli N, Aicale R, Taunton J. Iliotibial band syndrome rehabilitation in female runners: a pilot randomized study. J Orthop Surg Res. 2020 May 24;15(1):188. doi: 10.1186/s13018-020-01713-7.
PMID: 32448384BACKGROUNDGeisler PR. Current Clinical Concepts: Synthesizing the Available Evidence for Improved Clinical Outcomes in Iliotibial Band Impingement Syndrome. J Athl Train. 2021 Aug 1;56(8):805-815. doi: 10.4085/1062-6050-548-19. Epub 2020 Dec 22.
PMID: 34375405BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed El Melhat, PhD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of MSK Physical Therapy at Cairo University.
Study Record Dates
First Submitted
June 19, 2026
First Posted
June 25, 2026
Study Start
June 10, 2026
Primary Completion (Estimated)
August 10, 2026
Study Completion (Estimated)
August 30, 2026
Last Updated
June 25, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share